Guselkumab Adds PsA Structural Damage Inhibition to Label

Guselkumab is the only IL-23 inhibitor that has been proven to help stop further structural damage in patients with active psoriatic arthritis.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/guselkumab-adds-psoriatic-arthritis-structural-damage-2026a1000i12?src=rss

Author :

Publish date : 2026-05-29 17:39:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Guselkumab Adds PsA Structural Damage Inhibition to Label

Reassuring Data for Two High-Efficacy MS Meds in Pregnancy

Here’s Everything Wrong With the Offshore Ebola Quarantine Plan

Related Posts

‘People don’t realise how at risk they are’: A day with an ambulance service in a heatwave

The sneaky maths trick for solving problems without answering them

2026 eclipse: 5 citizen science projects you can contribute to

Taylor Swift-inspired cycle from Paris to London for Rori

Vapes to have less enticing names and flavours to protect children

Bollywood actor Kalki Koechlin’s play on motherhood’s messier side wows audience

‘People don’t realise how at risk they are’: A day with an ambulance service in a heatwave

The sneaky maths trick for solving problems without answering them

2026 eclipse: 5 citizen science projects you can contribute to

Taylor Swift-inspired cycle from Paris to London for Rori

Vapes to have less enticing names and flavours to protect children

Bollywood actor Kalki Koechlin’s play on motherhood’s messier side wows audience

Targeted Therapy Reverses Weight Gain From Rare Cause of Obesity

Newer Diabetes Drugs, Including GLP-1 Agonists, Tied to Autoimmunity Risk

Categories

Archives